Tumor necrosis after TACE can induce immune activation and upregulate the expression of PD-1 [18, 40], and anti-angiogenic therapy can reduce the immunosuppression of the tumor immune microenvironment and promote the infiltration of tumor T cells [41]. This evidence concerns the gene PDCD1 and neoplasm.